Literature DB >> 9215126

MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas.

Y Ajioka1, H Watanabe, J R Jass.   

Abstract

AIMS: To examine the expression of MUC1 and MUC2 apomucins and distribution of MUC phenotypes (MUC2+/ MUC-, MUC2+/MUC1+, MUC2-/ MUC1+, MUC2-/MUC1-) in colorectal tubular adenomas in order to compare the distribution of phenotypes in flat and polypoid adenomas.
METHODS: Endoscopically resected specimens of 35 flat and 15 polypoid tubular adenomas measuring less than 10 mm were examined and compared for the expression of MUC1 (MUSE11) and MUC2 (CCP58) and combined MUC phenotype distribution using conventional immunohistochemistry.
RESULTS: There was no significant difference between flat and polypoid adenomas in their expression of MUC1 and MUC2 and the MUC phenotype distribution when stratified by grade of histological atypia. Adenomas with low grade atypia showed more extensive MUC2 expression than MUC1 (MUC2+/MUC1-phenotype). Expression of MUC1 was more extensive in adenomas with high grade atypia and the majority displayed either MUC2+/ MUC1+ or MUC2-/MUC1+ phenotypes.
CONCLUSIONS: MUC2/MUC1 phenotypes were similar in flat and polypoid adenomas when stratified by grade of atypia. High grade atypia was characterised by reduced MUC2 and increased MUC1 expression in both types of adenoma. The phenotype MUC2-/MUC1+ occurs in tubular adenomas and cannot be a specific marker for de novo colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215126      PMCID: PMC499945          DOI: 10.1136/jcp.50.5.417

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  24 in total

1.  A biochemical and immuno-electron microscopical analysis of chondroitin sulphate-rich proteoglycans in human alveolar bone.

Authors:  A J Smith; S K Singhrao; G R Newman; R J Waddington; G Embery
Journal:  Histochem J       Date:  1997-01

2.  Flat adenoma and flat mucosal carcinoma (IIb type)--a new precursor of colorectal carcinoma? Report of two cases.

Authors:  M Adachi; T Muto; Y Morioka; T Ikenaga; M Hara
Journal:  Dis Colon Rectum       Date:  1988-03       Impact factor: 4.585

3.  Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.

Authors:  P X Xing; J Prenzoska; G T Layton; P L Devine; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

4.  The evolution of cancer of the colon and rectum.

Authors:  T Muto; H J Bussey; B C Morson
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features.

Authors:  T Muto; J Kamiya; T Sawada; F Konishi; K Sugihara; Y Kubota; M Adachi; S Agawa; Y Saito; Y Morioka
Journal:  Dis Colon Rectum       Date:  1985-11       Impact factor: 4.585

6.  Pathogenesis of polyps (adenomas).

Authors:  S R Hamilton
Journal:  Dis Colon Rectum       Date:  1983-06       Impact factor: 4.585

7.  Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.

Authors:  S B Ho; S L Ewing; C K Montgomery; Y S Kim
Journal:  Oncol Res       Date:  1996       Impact factor: 5.574

8.  Mucin gene expression in colonic tissues and cell lines.

Authors:  S Ogata; H Uehara; A Chen; S H Itzkowitz
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  Flat adenomas of the colon.

Authors:  R A Wolber; D A Owen
Journal:  Hum Pathol       Date:  1991-01       Impact factor: 3.466

10.  Recognition of the polypeptide core of mucin by monoclonal antibody MUSE11 against an adenocarcinoma-associated antigen.

Authors:  Y Hinoda; N Nakagawa; Y Ohe; H Kakiuchi; M Tsujisaki; K Imai; A Yachi
Journal:  Jpn J Cancer Res       Date:  1990-12
View more
  12 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  Relationship between biological behavior and phenotypic expression in undifferentiated-type gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Yoshihiko Maehara; Masazumi Tsuneyoshi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

3.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

4.  Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.

Authors:  A Lugli; I Zlobec; K Baker; P Minoo; L Tornillo; L Terracciano; J R Jass
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

Review 5.  Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.

Authors:  Jason Lohmueller; Olivera J Finn
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

6.  Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.

Authors:  Yuki Fukumura; Yasuni Nakanuma; Yuko Kakuda; Masaru Takase; Takashi Yao
Journal:  Virchows Arch       Date:  2017-05-26       Impact factor: 4.064

7.  Peritoneal recurrence of gastric cancer with mucin phenotype 12 years after curative resection: report of a case.

Authors:  Ryuusuke Aihara; Erito Mochiki; Sayaka Ohotake; Yoichi Kamiyama; Teturo Ohono; Hiroyuki Kuwano; Kohei Kurokawa; Kazuhiro Suzuki
Journal:  Surg Today       Date:  2007-03-26       Impact factor: 2.549

8.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

9.  Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: its relationship with the clinicopathologic factors.

Authors:  Ryuusuke Aihara; Erito Mochiki; Yoichi Kamiyama; Hitoshi Kamimura; Takayuki Asao; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 10.  Cancer immunoprevention.

Authors:  Olivera J Finn; Pamela L Beatty
Journal:  Curr Opin Immunol       Date:  2016-01-19       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.